Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Titan Pharmaceuticals Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −3 vs. Q2 2022
- Shares held
- 1.05M
- +389.0K (+58.5%) vs. Q2 2022
- Total value
- $1.14M
- +$765.0K (+206.2%) vs. Q2 2022
- New holders
- 4
- 3 more added
- Sold out
- 7
- 5 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TTNP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $69 |
| Q1 2026 | 6 | $130 |
| Q4 2025 | 4 | $154 |
| Q3 2025 | 18 | $107.1K |
| Q2 2025 | 20 | $158.3K |
| Q1 2025 | 17 | $51.9K |
| Q4 2024 | 15 | $9.41K |
| Q3 2024 | 16 | $88.5K |
| Q2 2024 | 18 | $179.3K |
| Q1 2024 | 17 | $230.0K |
| Q4 2023 | 24 | $408.2K |
| Q3 2023 | 27 | $497.8K |
| Q2 2023 | 25 | $632.7K |
| Q1 2023 | 22 | $787.4K |
| Q4 2022 | 23 | $757.9K |
| Q3 2022 | 21 | $1.14M |
| Q2 2022 | 24 | $371.0K |
| Q1 2022 | 24 | $1.24M |
| Q4 2021 | 24 | $430.0K |
| Q3 2021 | 22 | $722.0K |
| Q2 2021 | 23 | $1.51M |
| Q1 2021 | 24 | $988.1K |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Titan Pharmaceuticals Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Truist Financial Corp | 625,089 | $675.0K | 0.00% | +625,089 | New |
| Renaissance Technologies LLC | 144,710 | $156.0K | 0.00% | −96,000−39.9% | Reduced |
| Vanguard Group Inc | 81,924 | $88.0K | 0.00% | +7,029+9.4% | Added |
| Geode Capital Management, LLC | 64,092 | $69.0K | 0.00% | +1,739+2.8% | Added |
| State Street Corp | 38,287 | $41.0K | 0.00% | +38,287 | New |
| Virtu Financial LLC | 28,331 | $31.0K | 0.00% | −34,002−54.5% | Reduced |
| FNY Investment Advisers, LLC | 28,025 | $30.0K | 0.02% | +28,025 | New |
| Millennium Management LLC | 17,467 | $19.0K | 0.00% | −45,639−72.3% | Reduced |
| Citadel Advisors LLC | 13,076 | $14.0K | 0.00% | +13,076 | New |
| UBS Group AG | 11,176 | $12.0K | 0.00% | −15,769−58.5% | Reduced |
| Level Financial Advisors, Inc. | 987 | $1.00K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 23 | $25 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 206 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 75 | $0 | 0.00% | −6−7.4% | Reduced |
| FMR LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 40 | $0 | 0.00% | +24+150.0% | Added |
| BlackRock Inc. | 60 | $0 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 14 | $0 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 2 | $0 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 844 | – | – | 00.0% | Unchanged |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −59,504−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −52,108−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −18,978−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,755−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −483−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Joseph P. Lucia & Associates, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |